Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 +0.06 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.09 | 52 Week High | $4.76 | |||
| Open | $2.07 | 52 Week Low | $1.46 | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $-1.91 | |||
| Volume | 5,697,136 | |||||
| (NASDAQ: LEGN) | Delayed: 29.34 +1.41 (5.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.93 | 52 Week High | $ | |||
| Open | $28.38 | 52 Week Low | $ | |||
| Day High | $29.46 | P/E | N/A | |||
| Day Low | $28.10 | EPS | $ | |||
| Volume | 3,664,370 | |||||
